Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2011.555
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Springer Science and Business Media LLC